Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -0.68EBITDA per Share
VS
Market
Sector
Industry
History
$ 7.05Close
$ 3.38 - $ 7.28 52-Week Range
Ticker Information
Ticker
DMACCompany Name
DIAMEDICA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDIAMEDICA THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
DMAC - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -29.42M | $ -0.68 | 1 | 42.96M |
| 3/31/2025 | $ -26.82M | $ -0.63 | 1 | 42.84M |
| 12/31/2024 | $ -24.3M | $ -0.6 | 1 | 40.4M |
| 9/30/2024 | $ -21.34M | $ -0.5 | 1 | 42.75M |
| 6/30/2024 | $ -19.74M | $ -0.52 | 1 | 38.07M |
| 3/31/2024 | $ -19.13M | $ -0.5 | 1 | 37.96M |
| 12/31/2023 | $ -19.16M | $ -0.59 | 1 | 32.57M |
| 9/30/2023 | $ -17.81M | $ -0.47 | 1 | 37.95M |
| 6/30/2023 | $ -16.33M | $ -0.6 | 1 | 27.31M |
| 3/31/2023 | $ -15.24M | $ -0.58 | 1 | 26.45M |
Key Performance Insights, Last 5 Years
- DIAMEDICA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.63.
- Over the past 5 years, DIAMEDICA THERAPEUTICS INC's average EBITDAPS has been $ -0.6.
- The median EBITDAPS for DIAMEDICA THERAPEUTICS INC during this period was $ -0.59
- DIAMEDICA THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -0.47.
- The lowest EBITDAPS recorded by DIAMEDICA THERAPEUTICS INC in the same timeframe $ -0.78
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for DIAMEDICA THERAPEUTICS INC is calculated as follows: EBITDA [ $ -10.47M ] / (Shares WA [ 16.69M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.63 ] DMAC - EBITDA per Share, Last 5 years
$ -0.78
Minimum
Dec 31, 2020
$ -0.47
Maximum
Sep 30, 2023
$ -0.6
Average
$ -0.59
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 13.95 |
| average | $ 2.01 |
| median | $ 0.99 |
| std | $ 4.26 |